Trial Information

Summary: Moderate to Severe Allergic Asthma

This research study is designed to evaluate the safety, tolerability and effectiveness of an experimental study drug called HAE1, an anti immunoglobulin E (IgE) antibody (a type of protein made by the immune system in response to a foreign substance) and is being tested in this study in adolescents and adults with moderate to severe allergic asthma with a wide range of serum total IgE levels.

You may qualify for this study if you:

• Are at least 18 years of age
• Have a history of moderate to severe asthma

You will not qualify for this study if you:

• Are pregnant and/or breast feeding a child
• Have an active lung disease other than asthma or any significant medical illness
• Have had any treatment with omalizumab and/or beta blocker medication
• Have a history of drug or alcohol abuse

For more information,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.